Navigation Links
Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial
Date:8/5/2008

the CD4 receptor found on both effector and regulatory T cells. MTRX1011A is designed to block the activation and function of T effector cells and to favor dominance of T regulatory cells. This unique mechanism of action has the potential to ameliorate autoimmune disease symptoms not only through its direct action on pathogenic CD4 T cells, but by impacting downstream effects of CD4 T cells such as B cell autoantibody production.

About Tolerx

In addition to the anti-CD4 monoclonal antibody program, Tolerx is currently developing otelixizumab, an anti-CD3 monoclonal antibody, for the treatment of autoimmune disease, specifically, type 1 diabetes with its collaboration partner, GlaxoSmithKline. Tolerx is also engaged in preclinical development of new monoclonal antibody product candidates that engage the body's immune system and promote and enhance immune responses. These antibodies are being assessed for potential benefit in the treatment of cancer, chronic viral diseases, and as an adjunct to vaccines. For more information, please visit http://www.tolerx.com.

Safe Harbor Statement

This press release contains certain statements that are preceded by, followed by, or that include the words "look forward," "will receive," "is expected to," "may have," "potential benefit" or similar expressions or the negation thereof. Such statements, which are not historical facts, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements regarding Genentech's activities with respect to further development of MTRX1011A, the realization by Tolerx of any additional payments related to MTRX1011A and the anticipated clinical progress and development of MTRX1011A are all forward-looking statements. Such forward-looking statements involve risks, uncertainties and other factors that may cause the actual performance or achievements of Tolerx to be m
'/>"/>

SOURCE Tolerx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
2. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
3. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105
4. Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845
5. MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
6. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
7. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
8. Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida
9. Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis
10. Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients
11. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 Research and Markets ( ... "Electro Surgical Market" report to their ... expected to achieve a CAGR of 7% for ... benefits for patients as well as surgeons such ... visible marks, bleeding control and improved accuracy are ...
(Date:5/5/2015)... -- IQPC,s 19 th Software Design for Medical Devices ... Summit Mr. Phani Bidarahalli , GM & Head of ... expert speaker faculty including senior executive from GE Healthcare, Philips ... The Hotel Kabuki in San Francisco . ... the event website, which can be accessed by visiting ...
(Date:5/5/2015)... Lymphatic pump treatment (LPT) shows promise in managing pneumonia ... study published in The Journal of the American ... on infected rats three times a day followed by ... pneumonia. After 96 hours, over 60 percent of the ... of rats who received levofloxacin alone. Commonly ...
Breaking Medicine Technology:Global Electro Surgical Market 2015 2Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 2Lymphatic Pump Treatment Enhances Antibiotic Effectiveness for Treating Pneumonia 2
(Date:5/5/2015)... (PRWEB) May 05, 2015 From ... the established leader in enabling enterprise collaboration ... to help customers speed up and simplify the ... technologies, AvePoint Solutions for Office 365 ... faster while ensuring sustainable user adoption and effectively ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Sunny skies and ... Island Park as nearly 400 runners and walkers participated in ... raising nearly $35,000. , The 5K and 10K ... about Lyme disease and to raise funds for tick-borne disease ... created by the recent merger of Lyme Research ...
(Date:5/5/2015)... May 05, 2015 " QuickPick Travel ” ... Report, which takes a look small, medium, and large businesses ... for NewsWatch and a business expert, conducted the business review ... to plan up to three weeks of vacation for free. ... and friends, and explore the world. And when people are ...
(Date:5/5/2015)... 2015 Information Innovators Inc. ... the federal government, today announced its acquisition of ... provides solutions exclusively to federal government customers through ... cyber security, health services, and program management support. ... credentials as a Third Party Assessment Organization (3PAO) ...
(Date:5/5/2015)... May 05, 2015 Rare Genomics ... a new study aimed at determining how crowdfunding can ... is an international non-profit providing rare disease patients with ... connections to scientists and researchers, and help for payment ... “I am excited to see how crowdfunding will not ...
Breaking Medicine News(10 mins):Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 3Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:Rare Genomics Institute to Study Impact of Crowdfunding on Rare Diseases 2
... whopping amount allocated for health in Andhra Pradesh, the state has ... and now the rate is stuck at 62 per 1000 live ... seen as a very slow rate and perhaps will take another ... doubt push Andhra Pradesh back in the achievement of the millennium ...
... the University of NSW in Sydney have identified a cue to ... 3D motion cue which is dynamic //half-occlusion. This is helpful in ... ,It appears as a free access on Association for Research ... principles of binocular geometry established by Leonardo da Vinci, Drs.Kevin Brooks ...
... Researchers at the Mayo Clinic have ... develop degenerative brain diseases around 11 ... //. The findings of the study ... at the Associated Professional Sleep Societies' ...
... study initiated by U.S. researchers on the medical histories ... were either blind or suffered weak eyesight, revealed that ... caused Vitamin A deficiency, leading to poor eyesight or ... issue of the British Journal of Ophthalmology. ...
... abandoned by her biological parents ... and left to drown in ... //. But the little infant ... undergone a critical heart surgery. ...
... has brought out the immense health benefits of fish ... attributes, even before //they arrive into the world. Even ... lowered with consumption of fish oil by the expectant ... because it directly impacts the unborn baby as well ...
Cached Medicine News:
For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p...
Refresh Contacts provides moisturizing relief from dryness and irritation associated with lens wear....
Specially formulated to lubricate and moisten lenses to help relieve irritation and dryness....
... Renu Multiplus preservative free ... and moisturize your eyes while ... The gentle preservative free formula ... may be sensitive to preservatives ...
Medicine Products: